A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo.

MLA

Shanafelt, A. B., et al. “A T-Cell-Selective Interleukin 2 Mutein Exhibits Potent Antitumor Activity and Is Well Tolerated in Vivo.” Nature Biotechnology, vol. 18, no. 11, Nov. 2000, pp. 1197–202. EBSCOhost, https://doi.org/10.1038/81199.

APA

Shanafelt, A. B., Lin, Y., Shanafelt, M. C., Forte, C. P., Dubois-Stringfellow, N., Carter, C., Gibbons, J. A., Cheng, S. L., Delaria, K. A., Fleischer, R., Greve, J. M., Gundel, R., Harris, K., Kelly, R., Koh, B., Li, Y., Lantz, L., Mak, P., Neyer, L., … Zolotorev, A. (2000). A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo. Nature Biotechnology, 18(11), 1197–1202. https://doi.org/10.1038/81199

Chicago

Shanafelt, A B, Y Lin, M C Shanafelt, C P Forte, N Dubois-Stringfellow, C Carter, J A Gibbons, et al. 2000. “A T-Cell-Selective Interleukin 2 Mutein Exhibits Potent Antitumor Activity and Is Well Tolerated in Vivo.” Nature Biotechnology 18 (11): 1197–1202. doi:10.1038/81199.